Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)

This study has been completed.
Information provided by:
AstraZeneca Identifier:
First received: March 7, 2008
Last updated: January 24, 2011
Last verified: January 2011